Evaluating the Antihyperalgesic Potential of Sildenafil–Metformin Combination and Its Impact on Biochemical Markers in Alloxan-Induced Diabetic Neuropathy in Rats.

MLA

Pușcașu, Ciprian, et al. “Evaluating the Antihyperalgesic Potential of Sildenafil–Metformin Combination and Its Impact on Biochemical Markers in Alloxan-Induced Diabetic Neuropathy in Rats.” Pharmaceuticals (14248247), vol. 17, no. 6, June 2024, p. 783. EBSCOhost, https://doi.org/10.3390/ph17060783.

APA

Pușcașu, C., Negreș, S., Zbârcea, C. E., Ungurianu, A., Ștefănescu, E., Blebea, N. M., & Chiriță, C. (2024). Evaluating the Antihyperalgesic Potential of Sildenafil–Metformin Combination and Its Impact on Biochemical Markers in Alloxan-Induced Diabetic Neuropathy in Rats. Pharmaceuticals (14248247), 17(6), 783. https://doi.org/10.3390/ph17060783

Chicago

Pușcașu, Ciprian, Simona Negreș, Cristina Elena Zbârcea, Anca Ungurianu, Emil Ștefănescu, Nicoleta Mirela Blebea, and Cornel Chiriță. 2024. “Evaluating the Antihyperalgesic Potential of Sildenafil–Metformin Combination and Its Impact on Biochemical Markers in Alloxan-Induced Diabetic Neuropathy in Rats.” Pharmaceuticals (14248247) 17 (6): 783. doi:10.3390/ph17060783.